Table 5 Clinical outcome of patients with ESR mutation treated with hormonal therapy.
Patient ID | Age | Metastasis | Mutations | Hormonal therapy | Status of disease |
|---|---|---|---|---|---|
P1 | 71 | Liver | ESR1,MYC, FGFR1,CCND1, FGF19,MDM2 | Yes | PD |
P2 | 57 | Liver | ESR1, EGFR, FGFR1, MDM2, MYC and PALB2 | Yes | PD |
P3 | 54 | Liver | ERBB2, ESR1, FGF19, FGFR1, MYC and TP53 | Yes | PD |
P4 | 52 | Mediastinum | ESR1 and BRCA2 | Yes | Stable |
P5 | 60 | Abdominal wall | ESR1, PIK3CA, FGF19 and ARID1A, | Yes | PD |
P6 | 53 | Liver | ESR1 | Yes | PD |
P7 | 44 | Liver | ESR1 and PALB2 | Yes | PD |
P8 | 62 | Liver | ESR1 and PIK3CA | Yes | Stable |
